FINAL PROGRAM - Society for Immunotherapy of Cancer

Poster Listings
167
BLOCKING B7-H4- MEDIATED T-CELL INHIBITION
TO ALTERTHETUMOR MICROENVIRONMENT
Denarda Dangaj 1,2 , Shree Joshi 1 , Daniel J. Powell Jr 1,3 , Aizhi Zhao 1 ,
Raphael Sandaltzopoulos 2 , Nathalie Scholler 1
1
Obstetrics and Gynecology, OCRC, University of Pennsylvania, School of
Medicine, Philadelphia, PA
2
Molecular Biology and Genetics, University of Thrace, Alexandroupolis,
Greece
3
Pathology and Laboratory Medicine, University of Pennsylvania, School
of Medicine, Philadelphia, PA
168
PD-1 MEDIATED REGULATION OFT CELL
DYSFUNCTION IN OVARIAN CANCER
MICROENVIRONMENT
Jaikumar Duraiswamy 1 , Gordon J. Freeman 2 , George Coukos 1
1
Ovarian Cancer Research Center, University of Pennsylvania,
Philadelphia, PA
2
Department of Medical Oncology, Dana-Farber Cancer Institute,
Harvard Medical School, Boston, MA
169
WITHDRAWN BY AUTHOR
170
mTERT VACCINE CHEMOTHERAPY COMBINATION
AUGMENT ANTIGEN-SPECIFIC IMMUNE RESPONSE
AND CONFER TUMOR PROTECTION
Stefano Ugel 1 , Jens Router 1 , John Facciponte 1 , Elisa Scarselli 1,2 ,
Carmela Mennuni 2 , Nicola La Monica 2 , George Coukos 1 , Andrea
Facciabene 1
1
Ovarian Cancer Research Center, University of Pennsylvania Medical
Center, Philadelphia, PA
2
Oncology, Istituto Ricerca Biologia Molecolare, Pomezia, Rome, Italy
171
ENFORCED M1 POLARIZATION OF TUMOR
MACROPHAGES INCREASES THE EFFICACY OF
RADIATION THERAPY AND CHEMOTHERAPY
Michael Gough 1 , Benjamin Cottam 1 , Cynthia Nguyen 1 , Talicia Savage 1 ,
Marka Crittenden 1,2
1
Providence Cancer Center, Earle A Chiles Research Institute, Portland,
OR
2
The Oregon Clinic, Portland, OR
172
DISTINCT STATES OF IMMUNE SUPPRESSION
IDENTIFIED USING CLUSTERED PHENOTYPES OF
CANCER PATIENTS
Michael P. Gustafson 1 , Mary L. Maas 1 , Courtney J. Liwski 1 , Yi Lin 4 ,
Pooja Hingorani 3 , Roberta H. Adams 2 , Dennis A. Gastineau 1 , Allan
B. Dietz 1
1
Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
2
Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
3
Pediatric Oncology, Phoenix Children’s Hospital, Phoenix, AZ
4
Hematology, Mayo Clinic, Rochester, MN
173
DISTINCT REGULATION OFTHE FUNCTION OF
SUBSET OF MYELOID DERIVED SUPPRESSOR
CELLS BY IFN-GAMMA
Lydia A. Haile, Firouzeh Korangy, Tim F. Greten
Medical Oncology Branch, National Institutes of Health, Bethesda, MD
174
WITHDRAWN BY AUTHOR
175
MICROVESICLES (EXOSOMES) DERIVED FROM
AML BLASTS CARRY IMMUNOSUPPRESSIVE
MOLECULES AND INTERFERE ON THE IMMUNE
CELL FUNCTIONS
Chang-Sook Hong, Patrick Schuler, Michael Boyiadzis, Theresa L.
Whiteside
University of Pittsburgh Cancer Institute, Pittsburgh, PA
176
ROLE OF IL6/IL8-NF-KB AXIS IN THE
IMMUNOSUPPRESSION AND RESISTANCE TO
IMMUNOTHERAPY
Yutaka Kawakami 1 , Hiroshi Nishio 1 , Tomonori Yaguchi 1 , Yoshie
Kawase 1 , Azusa Ohizumi 1 , Shinobu Noji 1 , Toshiharu Sakurai 1 , Kazuo
Umezawa 2 , Tomonobu Fujita 1
1
Division of Cellular Signaling, Institute for Advanced Medical Research,
Keio University School of Medicine, Tokyo, Japan
2
Department of Applied Chemistry, Faculty of Science and Technology,
Keio University, Kanagawa, Japan
177
RE-PROGRAMMING OF TUMOR ASSOCIATED
T-REGULATORY CELLS FOR IMPROVED CANCER
IMMUNOTHERAPY
Mehmet O. Kilinc, Jamie Harden, Lauren Virtuoso, Nejat Egilmez
Microbiology and Immunology, State University of New York at Buffalo,
Buffalo, NY
76
FINAL PROGRAM • SITC 26 TH ANNUAL MEETING
November 4-6, 2011 • North Bethesda, MD • www.sitcancer.org